6-118558662-G-C

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_Strong BP6_Moderate BA1

The NM_001042475.3(CEP85L):c.1020+6867C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

• Frequency: Genomes: 𝑓 0.43 (9054 hom., cov: 17)
• Consequence: CEP85L NM_001042475.3 intron
• Clinical Significance: Benign criteria provided, single submitter B:1
• Conservation: PhyloP100: -2.52

Genes affected

CEP85L (HGNC:21638): (centrosomal protein 85 like) The protein encoded by this gene was identified as a breast cancer antigen. Nothing more is known of its function at this time. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2010]

PLN (HGNC:9080): (phospholamban) The protein encoded by this gene is found as a pentamer and is a major substrate for the cAMP-dependent protein kinase in cardiac muscle. The encoded protein is an inhibitor of cardiac muscle sarcoplasmic reticulum Ca(2+)-ATPase in the unphosphorylated state, but inhibition is relieved upon phosphorylation of the protein. The subsequent activation of the Ca(2+) pump leads to enhanced muscle relaxation rates, thereby contributing to the inotropic response elicited in heart by beta-agonists. The encoded protein is a key regulator of cardiac diastolic function. Mutations in this gene are a cause of inherited human dilated cardiomyopathy with refractory congestive heart failure, and also familial hypertrophic cardiomyopathy. [provided by RefSeq, Apr 2016]

ACMG classification

Verdict is Benign. Variant got -14 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.92).
• BP6: Variant 6-118558662-G-C is Benign according to our data. Variant chr6-118558662-G-C is described in ClinVar as [Benign]. Clinvar id is 1260729.Status of the report is criteria_provided_single_submitter, 1 stars.
• BA1: GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.494 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
CEP85L	NM_001042475.3	c.1020+6867C>G		intron_variant		ENST00000368491.8
PLN	NM_002667.5	c.-97-163G>C		intron_variant		ENST00000357525.6

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
PLN	ENST00000357525.6	c.-97-163G>C		intron_variant		1	NM_002667.5	P1
CEP85L	ENST00000368491.8	c.1020+6867C>G		intron_variant		1	NM_001042475.3	P1

Frequencies

GnomAD3 genomes AF: 0.425 AC: 47328 AN: 111232 Hom.: 9060 Cov.: 17

Gnomad AFR AF: 0.358

Gnomad AMI AF: 0.393

Gnomad AMR AF: 0.300

Gnomad ASJ AF: 0.424

Gnomad EAS AF: 0.271

Gnomad SAS AF: 0.436

Gnomad FIN AF: 0.424

Gnomad MID AF: 0.500

Gnomad NFE AF: 0.499

Gnomad OTH AF: 0.393

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.425 AC: 47327 AN: 111300 Hom.: 9054 Cov.: 17 AF XY: 0.413 AC XY: 21991 AN XY: 53228

Gnomad4 AFR AF: 0.358

Gnomad4 AMR AF: 0.299

Gnomad4 ASJ AF: 0.424

Gnomad4 EAS AF: 0.271

Gnomad4 SAS AF: 0.434

Gnomad4 FIN AF: 0.424

Gnomad4 NFE AF: 0.499

Gnomad4 OTH AF: 0.393

Alfa AF: 0.358 Hom.: 114

ClinVar

Significance: Benign

Submissions summary: Benign:1

Revision: criteria provided, single submitter

Submissions by phenotype

not provided Benign:1

Benign, criteria provided, single submitter

clinical testing

GeneDx

Aug 18, 2019

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.92
Cadd	Benign	0.79
Dann	Benign	0.20

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs113205166; hg19: chr6-118879825; COSMIC: COSV62646279;